| 2025-12-12 |
详情>>
内部人交易：
Yokozuka Noriko等共交易5笔
|
| 2025-10-30 |
详情>>
股本变动：
变动后总股本14792.37万股
变动原因 ▼▲
- 原因：
- From June 30, 2025 to September 30, 2025
Shares issued upon exercise of options
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.45美元,归母净利润-6613.5万美元,同比去年增长55.93%
|
| 2025-10-30 |
财报披露：
美东时间 2025-10-30 盘前发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益0.17美元,归母净利润2452.50万美元,同比去年增长140.27%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益0.38美元,归母净利润5668.60万美元,同比去年增长168.66%
|
| 2025-04-18 |
股东大会：
将于2025-05-29召开股东大会
会议内容 ▼▲
- 1.To elect as directors the seven nominees as set forth in the accompanying Proxy Statement with terms expiring at the 2026 Annual Meeting of Stockholders, or until their respective successors are elected and qualified;
2.To approve, on an advisory basis, the compensation of our named executive officers (“Say on Pay”);
3.To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025;
4.To transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|
| 2025-02-20 |
详情>>
业绩披露：
2024年年报每股收益-0.04美元,归母净利润-590.5万美元,同比去年增长-108.75%
|
| 2025-02-20 |
详情>>
业绩披露：
2022年年报每股收益0.57美元,归母净利润9175.80万美元,同比去年增长113.45%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.03美元,归母净利润-1.5亿美元,同比去年增长-285.9%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-0.42美元,归母净利润-6090.8万美元,同比去年增长-199.13%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.57美元,归母净利润-8255.8万美元,同比去年增长-975.39%
|
| 2024-04-12 |
股东大会：
将于2024-05-23召开股东大会
会议内容 ▼▲
- 1.To elect as directors the eight nominees as set forth in the accompanying Proxy Statement with terms expiring at the 2025 Annual Meeting of Shareholders, or until their respective successors are elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers (“Say on Pay”).
3.To approve the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2024, and KPMG Audit S.à r.l. as the statutory auditor of the Company for the year ending December 31, 2024.
4.To approve the Company’s annual accounts (the “Annual Accounts”) prepared in accordance with accounting principles generally accepted in Luxembourg (“Luxembourg GAAP”) for the 2023 financial year.
5.To approve the Company’s audited consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) (the “Consolidated Financial Statements”) for the 2023 financial year.
6.To allocate the results shown in the Annual Accounts for the 2023 financial year.
7.To discharge each of the directors of the Company for the performance of their mandates as directors of the Company in relation to the 2023 financial year.
8.To approve the compensation of certain of the non-employee independent directors of the Company for 2023.
9.To approve and ratify a share repurchase program whereby the Company may repurchase outstanding Ordinary Shares of the Company within certain limits (the “Share Repurchase Program”).
10.To transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|
| 2024-02-22 |
详情>>
业绩披露：
2023年年报每股收益0.44美元,归母净利润6748.60万美元,同比去年增长-26.45%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.52美元,归母净利润8072.70万美元,同比去年增长-46.93%
|
| 2023-05-01 |
股东大会：
将于2023-06-22召开股东大会
会议内容 ▼▲
- 1.To elect as directors the seven nominees as set forth in the accompanying Proxy Statement with terms expiring at the 2024 Annual Meeting of Shareholders, or until their respective successors are elected and qualified;
2.To approve, on an advisory basis, the compensation of our named executive officers (“Say on Pay”);
3.To approve, on an advisory basis, the frequency of the advisory vote on the compensation of our named executive officers (“Say on Frequency”);
4.To approve the appointment of BDO USA, LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023, and BDO Audit SA as the statutory auditor of the Company for the year ending December 31, 2023;
5.To approve the Company’s annual accounts (the “Annual Accounts”) prepared in accordance with accounting principles generally accepted in Luxembourg (“Luxembourg GAAP”) for the 2022 financial year;
6.To approve the Company’s audited consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) (the “Consolidated Financial Statements”) for the 2022 financial year;
7.To allocate the results shown in the Annual Accounts for the 2022 financial year;
8.To discharge each of the directors of the Company for the performance of their mandates as directors of the Company in relation to the 2022 financial year;
9.To approve the compensation of certain of the non-employee independent directors of the Company for 2022;
10.To transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|
| 2022-05-02 |
股东大会：
将于2022-07-21召开股东大会
会议内容 ▼▲
- 1.To elect as directors the seven nominees as set forth in the accompanying proxy statement with terms expiring at the 2023 Annual Meeting of Shareholders, or until their respective successors are elected and qualified;
2.To approve the appointment of BDO USA, LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2022 and BDO Audit SA as the statutory auditor of the Company for the year ending December 31, 2022;
3.To approve the Company’s annual accounts (the "Annual Accounts") prepared in accordance with accounting principles generally accepted in Luxembourg (“Luxembourg GAAP”) for the financial period from June 21, 2021 (inception) to December 31, 2021;
4.To approve the Company’s audited consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) (the “Consolidated Financial Statements”) for the financial period from June 21, 2021 (inception) to December 31, 2021;
5.To allocate the results shown in the Annual Accounts for the financial period from June 21, 2021 (inception) to December 31, 2021;
6.To discharge each of the directors of the Company for the performance of their mandates as directors of the Company in relation to the financial period from June 21, 2021 (inception) to December 31, 2021;
7.To approve the compensation of certain of the non-employee independent directors of the Company for 2021;
8.To approve and ratify a share repurchase program whereby the Company may repurchase outstanding ordinary shares of the Company within certain limits (the “Share Repurchase Program”);
9.To transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|